Profile | GDS5420 / 204361_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 89.36 | 40 |
GSM1296119 | B_lesional_pre-dose | 312.9 | 60 |
GSM1296076 | C_lesional_pre-dose | 185.63 | 53 |
GSM1296092 | D_lesional_pre-dose | 195.15 | 54 |
GSM1296103 | E_lesional_pre-dose | 90.38 | 40 |
GSM1296078 | F_lesional_pre-dose | 156.22 | 50 |
GSM1296107 | G_lesional_pre-dose | 318.23 | 60 |
GSM1296109 | H_lesional_pre-dose | 142 | 45 |
GSM1296080 | I_lesional_pre-dose | 92.75 | 42 |
GSM1296090 | J_lesional_pre-dose | 185.35 | 52 |
GSM1296074 | K_lesional_pre-dose | 148 | 50 |
GSM1296111 | L_lesional_pre-dose | 314.46 | 60 |
GSM1296099 | M_lesional_pre-dose | 115.19 | 43 |
GSM1296086 | O_lesional_pre-dose | 115.47 | 45 |
GSM1296117 | P_lesional_pre-dose | 250.99 | 55 |
GSM1296113 | Q_lesional_pre-dose | 314.88 | 59 |
GSM1296096 | R_lesional_pre-dose | 106.11 | 43 |
GSM1296105 | S_lesional_pre-dose | 95.89 | 40 |
GSM1296098 | T_lesional_pre-dose | 95.38 | 40 |
GSM1296101 | U_lesional_pre-dose | 82.78 | 38 |
GSM1296121 | V_lesional_pre-dose | 230.43 | 54 |
GSM1296088 | W_lesional_pre-dose | 188.54 | 52 |
GSM1296082 | X_lesional_pre-dose | 184.66 | 53 |
GSM1296115 | Y_lesional_pre-dose | 247.6 | 55 |
GSM1296084 | Z_lesional_pre-dose | 122.79 | 45 |
GSM1296072 | B_lesional_day8 | 273.88 | 57 |
GSM1296069 | L_lesional_day8 | 318.96 | 59 |
GSM1296071 | P_lesional_day8 | 270.99 | 56 |
GSM1296070 | Y_lesional_day8 | 212.59 | 52 |
GSM1296073 | V_lesional_day8 | 205.62 | 53 |
GSM1296034 | A_lesional_day15 | 88.87 | 38 |
GSM1296041 | G_lesional_day15 | 233.07 | 55 |
GSM1296035 | R_lesional_day15 | 101.17 | 42 |
GSM1296038 | U_lesional_day15 | 106.71 | 43 |
GSM1296047 | B_lesional_day15 | 251.7 | 55 |
GSM1296039 | E_lesional_day15 | 207.61 | 53 |
GSM1296042 | H_lesional_day15 | 272.1 | 57 |
GSM1296043 | L_lesional_day15 | 231.33 | 53 |
GSM1296037 | M_lesional_day15 | 82.14 | 37 |
GSM1296046 | P_lesional_day15 | 240.44 | 54 |
GSM1296044 | Q_lesional_day15 | 315.38 | 59 |
GSM1296045 | Y_lesional_day15 | 249.63 | 55 |
GSM1296025 | C_lesional_day15 | 44.79 | 29 |
GSM1296033 | D_lesional_day15 | 119.52 | 45 |
GSM1296027 | I_lesional_day15 | 114.96 | 46 |
GSM1296032 | J_lesional_day15 | 220.88 | 54 |
GSM1296024 | K_lesional_day15 | 66.17 | 36 |
GSM1296031 | W_lesional_day15 | 133.14 | 45 |
GSM1296028 | X_lesional_day15 | 134.58 | 46 |
GSM1296029 | Z_lesional_day15 | 71.19 | 37 |
GSM1296026 | F_lesional_day15 | 54.53 | 32 |
GSM1296030 | O_lesional_day15 | 43.83 | 32 |
GSM1296040 | S_lesional_day15 | 47.53 | 29 |
GSM1296036 | T_lesional_day15 | 80.27 | 37 |
GSM1296048 | V_lesional_day15 | 204.9 | 52 |
GSM1296059 | A_lesional_day43 | 81.46 | 39 |
GSM1296066 | G_lesional_day43 | 236.88 | 54 |
GSM1296060 | R_lesional_day43 | 99.36 | 42 |
GSM1296063 | U_lesional_day43 | 126.39 | 45 |
GSM1296064 | E_lesional_day43 | 145.37 | 48 |
GSM1296067 | H_lesional_day43 | 156.79 | 46 |
GSM1296062 | M_lesional_day43 | 97.59 | 41 |
GSM1296068 | Q_lesional_day43 | 318.75 | 59 |
GSM1296050 | C_lesional_day43 | 224.17 | 54 |
GSM1296057 | D_lesional_day43 | 174.2 | 50 |
GSM1296052 | I_lesional_day43 | 137.8 | 48 |
GSM1296054 | J_lesional_day43 | 100.58 | 41 |
GSM1296049 | K_lesional_day43 | 101.91 | 42 |
GSM1296055 | W_lesional_day43 | 128.65 | 44 |
GSM1296053 | X_lesional_day43 | 77.74 | 38 |
GSM1296058 | Z_lesional_day43 | 39.16 | 29 |
GSM1296051 | F_lesional_day43 | 157.6 | 50 |
GSM1296056 | O_lesional_day43 | 93.64 | 42 |
GSM1296065 | S_lesional_day43 | 174.9 | 50 |
GSM1296061 | T_lesional_day43 | 54.84 | 31 |
GSM1296095 | A_non-lesional_pre-dose | 206.96 | 53 |
GSM1296120 | B_non-lesional_pre-dose | 312.54 | 59 |
GSM1296077 | C_non-lesional_pre-dose | 83.79 | 40 |
GSM1296093 | D_non-lesional_pre-dose | 70.71 | 35 |
GSM1296104 | E_non-lesional_pre-dose | 214.87 | 53 |
GSM1296079 | F_non-lesional_pre-dose | 87.09 | 40 |
GSM1296108 | G_non-lesional_pre-dose | 270.69 | 57 |
GSM1296110 | H_non-lesional_pre-dose | 251.43 | 54 |
GSM1296081 | I_non-lesional_pre-dose | 33.91 | 27 |
GSM1296091 | J_non-lesional_pre-dose | 235.18 | 56 |
GSM1296075 | K_non-lesional_pre-dose | 225.97 | 56 |
GSM1296112 | L_non-lesional_pre-dose | 239.56 | 53 |
GSM1296100 | M_non-lesional_pre-dose | 69.39 | 35 |
GSM1296087 | O_non-lesional_pre-dose | 61.09 | 36 |
GSM1296118 | P_non-lesional_pre-dose | 285.5 | 57 |
GSM1296114 | Q_non-lesional_pre-dose | 369.05 | 62 |
GSM1296097 | R_non-lesional_pre-dose | 129.98 | 45 |
GSM1296106 | S_non-lesional_pre-dose | 170.68 | 49 |
GSM1296102 | U_non-lesional_pre-dose | 71.3 | 35 |
GSM1296122 | V_non-lesional_pre-dose | 186.09 | 50 |
GSM1296089 | W_non-lesional_pre-dose | 128.23 | 44 |
GSM1296083 | X_non-lesional_pre-dose | 111.33 | 43 |
GSM1296116 | Y_non-lesional_pre-dose | 271.91 | 56 |
GSM1296085 | Z_non-lesional_pre-dose | 84.19 | 39 |